Jun 29, 2020 4:15pm EDT Lexaria Bioscience Engages Investor Relations and Capital Markets Advisory Firm for its Shareholder Communications Program
Jun 18, 2020 6:30am EDT Lexaria Bioscience Applies for NIH Grant for COVID-19 Therapy Studies and Receives New Expanded Health Canada License
Jun 01, 2020 4:35pm EDT Lexaria Bioscience Engages PCG Advisory, Inc, to Provide Investor Relations Services
Apr 21, 2020 6:20am EDT Lexaria Bioscience Files New Patent Utilizing DehydraTECH Technology for Treatment of Infectious Diseases Including COVID-19
Mar 23, 2020 6:20am EDT Lexaria Bioscience Expands Pharmaceutical Division to Include Lipophilic Antiviral Active Molecules for COVID-19 Treatment
